Application Information

This drug has been submitted to the FDA under the reference 050719/001.

Names and composition

"HELIDAC" is the commercial name of a drug composed of BISMUTH SUBSALICYLATE and METRONIDAZOLE and TETRACYCLINE HYDROCHLORIDE.

Forms

ApplId/ProductId Drug name Active ingredient Form Strenght
050719/001 HELIDAC BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE TABLET, CHEWABLE, TABLET, CAPSULE/ORAL 262.4MG,N per A,N per A and N per A,250MG,N per A and N per A,N per A,500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

Similar Active Ingredient

ApplId/ProductId Drug name Active ingredient Form Strenght
050719/001 HELIDAC BISMUTH SUBSALICYLATE; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE TABLET, CHEWABLE, TABLET, CAPSULE/ORAL 262.4MG,N per A,N per A and N per A,250MG,N per A and N per A,N per A,500MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**

Ask a doctor

A licensed doctor will try to answer your question for free as quickly as possible. Free of charge during the beta period.

Related

Browse by letter
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

© Medications.li 2015-2017 - All rights reserved